Insurances & Business

News Economy Business Investment Banks Credits

Pfizer Warns of Lung Cancer With Inhaled Insulin

NEW YORK (Reuters) - Pfizer Inc <PFE.N> and Nektar
Therapeutics <NKTR.O> said on Wednesday clinical trials of the
inhaled insulin Exubera found increased cases of lung cancer,
leading Nektar to stop seeking a marketing partner for the
troubled product and abandon it.

Leave a Reply »»

Similar/Related/News: